Abstract
Objective: We performed a case–control study at Kaiser Permanente Northwest to assess the association between digital rectal examination (DRE) and prostate-specific antigen (PSA) testing, separately and together, and prostate cancer mortality. Methods: We identified 171 KPNW members who died as a result of prostate cancer from 1992 to 1999 and 342 randomly-selected KPNW members matched to the cases on age, sex, and length of plan membership. History of screening was determined from medical records and laboratory databases for cases and controls. Results: DRE and/or PSA screening at any time up to and including the case diagnosis date had taken place among 69.0% of cases and 74.6% of controls. After using logistic regression analysis to adjust for matching variables and a provider diagnosis of benign prostatic hypertrophy (BPH), we found an inverse association between receipt of a prostate cancer screening test and prostate cancer mortality (odds ratio (OR): 0.70, 95% confidence interval (CI): 0.46 – 1.1). Most of the screening tests were DREs, and it was not possible to assess the separate influence of PSA screening. Conclusions: The results of this study suggest that men who have been screened for prostate cancer have a reduced risk of dying as a result of this disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jemal A, Murray T, Samuels A, et al. (2003) Cancer Statistics, 2003. CA Cancer J Clin 53: 5-26.
Gohagan JD, Prorok PC, Kramer BS, et al. (1995) The prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. Cancer 75(suppl 7): 1869-1873.
de Koning HJ, Auvinen A, Berenguer Sanchez A, et al. (2002) Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97: 237-244.
ERSPC(2002) Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for prostate Cancer (ERSPC) trial. Int J Cancer 98: 268-273.
Clarke EA, Anderson TW (1979) Does screening by ‘Pap’ smears help prevent cervical cancer? A case-control study. Lancet 314: 1-4.
IARC Working Group(1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. BMJ 293: 659-664.
Verbeek ALM, Hendriks JHCL, Holland R, et al. (1984) Reduction of breast cancer mortality through mass screening with modern mammography. Lancet 323: 1222-1224.
Palli D, Del Turco MR, Buiatti E, et al. (1986) A case-control study of the e.cacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer 38: 501-504.
Ebeling K, Nischan P (1987) Screening for lung cancer: results from a case-control study. Int J Cancer 40: 141-144.
Sovue T, Suzuki T, Naruke T (1992) Japanese Lung Cancer Screening Research Group: a case-control study for evaluating lung-cancer screening in Japan. Int J Cancer 50: 230-237.
Selby JV, Friedman GD, Quesenberry CP, et al. (1993) E.ect of fecal occult blood testing on mortality from colorectal cancer: a case-control study. Ann Int Med 118: 1-6.
Lazovich D, Weiss NS, Stevens HG, et al. (1996) A case-control study to evaluate e.cacy of screening for faecal occult blood. J Med Screen 2: 84-89.
Selby JV, Friedman GD, Quesenberry CP, et al. (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. NEJM 326: 653-657.
Newcomb PA, Norfleet RG, Storer BE, et al. (1992) Screening sigmoidoscopy and colorectal cancer mortality. JNCI 84: 1572-1575.
Friedman GD, Hiatt RA, Quesenberry CP Jr, et al. (1991) Casecontrol study of screening for prostatic cancer by digital rectal examinations. Lancet 337: 1526-1529.
Richert-Boe KA, Humphrey LL, Glass AG, et al. (1998) Screening digital rectal examination and prostate cancer mortality: a case-control study. J Med Screen 5: 99-103.
Jacobsen SJ, Bergstralh EJ, Katusic SK, et al. (1998) Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology 52: 173-179.
Weiss NS, McKnight B, Stevens NH (1992) Approaches to the analysis of case-control studies of the e.cacy of screening for cancer. Am J Epidemiol 135: 817-823.
Weiss NS, Dhillon P (in press). The validity of case-control studies of the e.cacy of cancer screening: overcoming non-random patterns of screening in the source population. Epidemiology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weinmann, S., Richert-Boe, K., Glass, A.G. et al. Prostate cancer screening and mortality: A case-control study (United States). Cancer Causes Control 15, 133–138 (2004). https://doi.org/10.1023/B:CACO.0000019473.83472.18
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000019473.83472.18